Table 1.
Factor | Function | |||
---|---|---|---|---|
Chro. | Normal BM | Leukemia | References | |
VEGFR-2 | 4q12 | Recovery and reconstitution of HSCs | Up regulation. | 29-31 |
AKT phosphorylation. | ||||
Apoptosis inhibition. | ||||
Induces drugresistance. | ||||
SCF | 12q22 | Maintenance of HSCs | Up regulation. | 32-35 |
Leukemic cells growth. | ||||
E-selectin | 1q24-25 | Promotesthe proliferation of HSCs | Survival of leukemic cells. | 36-38 |
Migration of leukemic cells to another location | ||||
NO | 7q35-36 | Differentiation to myeloid progenitors | Induces apoptosis in leukemia cells. | 39-41 |
CXCL-12 | 10q11 | Maintenance of HSCs | Up regulation. | 42-45 |
Survival and proliferation of leukemia cells | ||||
DLL1,4 (Notch ligand) | 6q27 15q21.1 | Expansion and exhaustionprevention of HSCs | Unfavorable prognosis. | 46-49 |
Jagged-1 | 20p12 | Regenerative of HSCs | Up regulation. | 50-52 |
Favorable prognosis. | ||||
Pleiotrophin | 7q33 | Expansion and retention of HSCs | Up regulation. | 53-55 |
Poor prognosis. |
VEGFR-2, vascular endothelial growth factor-2; HSC, hematopoietic stem cell; SCF, stem cell factor; E-selectin, endothelial selectin; CXCL-12, C-X-C motif chemokine 12; NO, nitric oxide; DLL, delta-like ligand.